AMGEN PRESENTS NEW DATA FROM PHASE 2 TRIAL OF DAZODALIBEP IN SJÖGREN'S SYNDROME AT ACR 2023PRNewsWire • 11/07/23
Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell ConditionPRNewsWire • 11/06/23
AMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES FOR ADULTS TREATED WITH KRYSTEXXA® (PEGLOTICASE)PRNewsWire • 11/02/23
AMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED RHEUMATOLOGY PIPELINE AND PORTFOLIOPRNewsWire • 11/01/23
Amgen Boosts Outlook Following Horizon Takeover, But Dips On Light Enbrel SalesInvestors Business Daily • 10/31/23